STIMULI: A randomised open-label phase II trial of consolidation with nivolumab and ipilimumab in limited-stage SCLC after standard of care chemo-radiotherapy conducted by ETOP and IFCT

Authors :: Sanjay Popat
Roswitha Kammler
Dirk De Ruysscher
A. Liston
H. Roschitzki
Barbara Ruepp
O. Dafni
Rolf A. Stahel
A.-C. Piguet
Rudolf Maibach
M. Finlayson
Martin Reck
George Coukos
C. Le Pechoux
Solange Peters
Zoi Tsourti
Daniel E. Speiser
J.L. Pujol
Source :: Annals of Oncology. 27:vi496
Publication Year :: 2016
Publisher :: Elsevier BV, 2016.

Subjects :: Oncology
Chemo-radiotherapy
medicine.medical_specialty
Standard of care
business.industry
Ipilimumab
Hematology
Surgery
Limited stage SCLC
Internal medicine
medicine
Nivolumab
Open label
business
medicine.drug

Tools